nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—testicular cancer—prostate cancer	0.357	1	CtDrD
Vinblastine—CYP3A4—prostate cancer	0.0328	1	CbGaD
Vinblastine—TUBB2B—Cabazitaxel—prostate cancer	0.0282	0.0667	CbGbCtD
Vinblastine—TUBB4A—Cabazitaxel—prostate cancer	0.0282	0.0667	CbGbCtD
Vinblastine—TUBB8—Cabazitaxel—prostate cancer	0.0282	0.0667	CbGbCtD
Vinblastine—TUBB2A—Cabazitaxel—prostate cancer	0.0282	0.0667	CbGbCtD
Vinblastine—TUBB3—Cabazitaxel—prostate cancer	0.0282	0.0667	CbGbCtD
Vinblastine—TUBB6—Cabazitaxel—prostate cancer	0.0282	0.0667	CbGbCtD
Vinblastine—TUBB1—Cabazitaxel—prostate cancer	0.0236	0.0558	CbGbCtD
Vinblastine—TUBB4B—Cabazitaxel—prostate cancer	0.0236	0.0558	CbGbCtD
Vinblastine—TUBB—Cabazitaxel—prostate cancer	0.0236	0.0558	CbGbCtD
Vinblastine—TUBB6—Docetaxel—prostate cancer	0.00946	0.0224	CbGbCtD
Vinblastine—TUBB8—Docetaxel—prostate cancer	0.00946	0.0224	CbGbCtD
Vinblastine—TUBB4A—Docetaxel—prostate cancer	0.00946	0.0224	CbGbCtD
Vinblastine—TUBB2B—Docetaxel—prostate cancer	0.00946	0.0224	CbGbCtD
Vinblastine—TUBB3—Docetaxel—prostate cancer	0.00946	0.0224	CbGbCtD
Vinblastine—TUBB2A—Docetaxel—prostate cancer	0.00946	0.0224	CbGbCtD
Vinblastine—ABCC1—Abiraterone—prostate cancer	0.00941	0.0222	CbGbCtD
Vinblastine—ABCC6—Etoposide—prostate cancer	0.00865	0.0204	CbGbCtD
Vinblastine—ABCB11—Ethinyl Estradiol—prostate cancer	0.00853	0.0202	CbGbCtD
Vinblastine—TUBB—Docetaxel—prostate cancer	0.00791	0.0187	CbGbCtD
Vinblastine—TUBB1—Docetaxel—prostate cancer	0.00791	0.0187	CbGbCtD
Vinblastine—TUBB4B—Docetaxel—prostate cancer	0.00791	0.0187	CbGbCtD
Vinblastine—ABCC6—Doxorubicin—prostate cancer	0.0059	0.0139	CbGbCtD
Vinblastine—ABCC2—Ethinyl Estradiol—prostate cancer	0.00449	0.0106	CbGbCtD
Vinblastine—ABCC1—Conjugated Estrogens—prostate cancer	0.00445	0.0105	CbGbCtD
Vinblastine—ABCC1—Mitoxantrone—prostate cancer	0.00404	0.00956	CbGbCtD
Vinblastine—SLC22A2—Estradiol—prostate cancer	0.00354	0.00837	CbGbCtD
Vinblastine—ABCC2—Conjugated Estrogens—prostate cancer	0.00329	0.00779	CbGbCtD
Vinblastine—ABCC1—Epirubicin—prostate cancer	0.00327	0.00774	CbGbCtD
Vinblastine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00312	0.00739	CbGbCtD
Vinblastine—CYP2D6—Bicalutamide—prostate cancer	0.00258	0.0061	CbGbCtD
Vinblastine—ABCC1—Etoposide—prostate cancer	0.00255	0.00603	CbGbCtD
Vinblastine—ABCB1—Estramustine—prostate cancer	0.00255	0.00602	CbGbCtD
Vinblastine—ABCB11—Doxorubicin—prostate cancer	0.00245	0.00579	CbGbCtD
Vinblastine—ABCC1—Docetaxel—prostate cancer	0.00233	0.00552	CbGbCtD
Vinblastine—CYP2D6—Abiraterone—prostate cancer	0.00214	0.00506	CbGbCtD
Vinblastine—ABCC2—Etoposide—prostate cancer	0.00189	0.00446	CbGbCtD
Vinblastine—ABCC1—Doxorubicin—prostate cancer	0.00174	0.00411	CbGbCtD
Vinblastine—ABCC2—Docetaxel—prostate cancer	0.00173	0.00408	CbGbCtD
Vinblastine—ABCB1—Cabazitaxel—prostate cancer	0.00168	0.00397	CbGbCtD
Vinblastine—CYP3A4—Bicalutamide—prostate cancer	0.00164	0.00388	CbGbCtD
Vinblastine—ABCB1—Estrone—prostate cancer	0.00164	0.00388	CbGbCtD
Vinblastine—CYP3A4—Estramustine—prostate cancer	0.00153	0.00361	CbGbCtD
Vinblastine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00146	0.00346	CbGbCtD
Vinblastine—CYP3A4—Abiraterone—prostate cancer	0.00136	0.00322	CbGbCtD
Vinblastine—CYP3A4—Flutamide—prostate cancer	0.00136	0.00322	CbGbCtD
Vinblastine—TUBD1—prostate gland—prostate cancer	0.00133	0.0328	CbGeAlD
Vinblastine—ABCC2—Doxorubicin—prostate cancer	0.00129	0.00304	CbGbCtD
Vinblastine—TUBE1—prostate gland—prostate cancer	0.00124	0.0307	CbGeAlD
Vinblastine—TUBD1—seminal vesicle—prostate cancer	0.00112	0.0277	CbGeAlD
Vinblastine—TUBG1—prostate gland—prostate cancer	0.00111	0.0275	CbGeAlD
Vinblastine—ABCB1—Conjugated Estrogens—prostate cancer	0.00107	0.00254	CbGbCtD
Vinblastine—TUBE1—seminal vesicle—prostate cancer	0.00105	0.026	CbGeAlD
Vinblastine—CYP3A4—Cabazitaxel—prostate cancer	0.00101	0.00238	CbGbCtD
Vinblastine—CYP3A4—Estrone—prostate cancer	0.000983	0.00232	CbGbCtD
Vinblastine—ABCB1—Mitoxantrone—prostate cancer	0.000976	0.00231	CbGbCtD
Vinblastine—ABCB1—Estradiol—prostate cancer	0.000942	0.00223	CbGbCtD
Vinblastine—TUBG1—seminal vesicle—prostate cancer	0.000941	0.0233	CbGeAlD
Vinblastine—TUBD1—urethra—prostate cancer	0.000887	0.022	CbGeAlD
Vinblastine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000876	0.00207	CbGbCtD
Vinblastine—TUBE1—urethra—prostate cancer	0.000832	0.0206	CbGeAlD
Vinblastine—ABCB1—Prednisone—prostate cancer	0.00081	0.00192	CbGbCtD
Vinblastine—TUBG1—renal system—prostate cancer	0.000758	0.0188	CbGeAlD
Vinblastine—TUBG1—urethra—prostate cancer	0.000745	0.0184	CbGeAlD
Vinblastine—Vincristine—RALBP1—prostate cancer	0.000705	0.431	CrCbGaD
Vinblastine—TUBD1—bone marrow—prostate cancer	0.000683	0.0169	CbGeAlD
Vinblastine—TUBA1A—prostate gland—prostate cancer	0.000644	0.0159	CbGeAlD
Vinblastine—CYP3A4—Conjugated Estrogens—prostate cancer	0.000643	0.00152	CbGbCtD
Vinblastine—TUBE1—bone marrow—prostate cancer	0.00064	0.0158	CbGeAlD
Vinblastine—JUN—prostate gland—prostate cancer	0.000638	0.0158	CbGeAlD
Vinblastine—ABCB1—Etoposide—prostate cancer	0.000615	0.00146	CbGbCtD
Vinblastine—TUBG1—Fulvestrant—Estradiol—prostate cancer	0.000594	0.404	CbGdCrCtD
Vinblastine—CYP3A4—Mitoxantrone—prostate cancer	0.000585	0.00138	CbGbCtD
Vinblastine—TUBD1—testis—prostate cancer	0.000584	0.0144	CbGeAlD
Vinblastine—TUBB8—testis—prostate cancer	0.000584	0.0144	CbGeAlD
Vinblastine—TUBG1—bone marrow—prostate cancer	0.000573	0.0142	CbGeAlD
Vinblastine—CYP3A4—Estradiol—prostate cancer	0.000565	0.00134	CbGbCtD
Vinblastine—ABCB1—Docetaxel—prostate cancer	0.000563	0.00133	CbGbCtD
Vinblastine—TUBB4A—prostate gland—prostate cancer	0.00055	0.0136	CbGeAlD
Vinblastine—TUBE1—testis—prostate cancer	0.000547	0.0135	CbGeAlD
Vinblastine—TUBA1A—seminal vesicle—prostate cancer	0.000545	0.0135	CbGeAlD
Vinblastine—JUN—seminal vesicle—prostate cancer	0.000539	0.0133	CbGeAlD
Vinblastine—TUBB2B—prostate gland—prostate cancer	0.000532	0.0132	CbGeAlD
Vinblastine—ABCC6—renal system—prostate cancer	0.000519	0.0128	CbGeAlD
Vinblastine—TUBB—prostate gland—prostate cancer	0.000503	0.0125	CbGeAlD
Vinblastine—TUBB2A—prostate gland—prostate cancer	0.000501	0.0124	CbGeAlD
Vinblastine—TUBB6—prostate gland—prostate cancer	0.000494	0.0122	CbGeAlD
Vinblastine—CYP3A4—urine—prostate cancer	0.000491	0.0122	CbGeAlD
Vinblastine—TUBG1—testis—prostate cancer	0.00049	0.0121	CbGeAlD
Vinblastine—CYP3A4—Prednisone—prostate cancer	0.000486	0.00115	CbGbCtD
Vinblastine—CYP2D6—urine—prostate cancer	0.000483	0.012	CbGeAlD
Vinblastine—NR5A1—testis—prostate cancer	0.000478	0.0118	CbGeAlD
Vinblastine—TUBA1A—epithelium—prostate cancer	0.000473	0.0117	CbGeAlD
Vinblastine—JUN—epithelium—prostate cancer	0.000469	0.0116	CbGeAlD
Vinblastine—TUBB1—bone marrow—prostate cancer	0.000456	0.0113	CbGeAlD
Vinblastine—TUBB2B—seminal vesicle—prostate cancer	0.00045	0.0111	CbGeAlD
Vinblastine—TUBA1A—renal system—prostate cancer	0.000439	0.0109	CbGeAlD
Vinblastine—JUN—renal system—prostate cancer	0.000435	0.0108	CbGeAlD
Vinblastine—TUBA1A—urethra—prostate cancer	0.000431	0.0107	CbGeAlD
Vinblastine—TUBB4B—prostate gland—prostate cancer	0.000429	0.0106	CbGeAlD
Vinblastine—JUN—urethra—prostate cancer	0.000427	0.0106	CbGeAlD
Vinblastine—TUBB—seminal vesicle—prostate cancer	0.000426	0.0105	CbGeAlD
Vinblastine—TUBB2A—seminal vesicle—prostate cancer	0.000423	0.0105	CbGeAlD
Vinblastine—TUBD1—lymph node—prostate cancer	0.000423	0.0105	CbGeAlD
Vinblastine—ABCB1—Doxorubicin—prostate cancer	0.00042	0.000992	CbGbCtD
Vinblastine—TUBB6—seminal vesicle—prostate cancer	0.000418	0.0103	CbGeAlD
Vinblastine—ABCC6—Podofilox—Etoposide—prostate cancer	0.000411	0.28	CbGdCrCtD
Vinblastine—TUBB3—testis—prostate cancer	0.000398	0.00986	CbGeAlD
Vinblastine—TUBE1—lymph node—prostate cancer	0.000397	0.00982	CbGeAlD
Vinblastine—CYP2D6—Doxorubicin—prostate cancer	0.000395	0.000935	CbGbCtD
Vinblastine—TUBB1—testis—prostate cancer	0.00039	0.00964	CbGeAlD
Vinblastine—TUBB4A—renal system—prostate cancer	0.000375	0.00928	CbGeAlD
Vinblastine—SLC22A2—renal system—prostate cancer	0.000373	0.00924	CbGeAlD
Vinblastine—CYP3A4—Etoposide—prostate cancer	0.000369	0.000872	CbGbCtD
Vinblastine—TUBB4B—seminal vesicle—prostate cancer	0.000363	0.00898	CbGeAlD
Vinblastine—TUBB6—epithelium—prostate cancer	0.000363	0.00898	CbGeAlD
Vinblastine—TUBB2B—renal system—prostate cancer	0.000363	0.00897	CbGeAlD
Vinblastine—TUBB2B—urethra—prostate cancer	0.000356	0.00881	CbGeAlD
Vinblastine—TUBG1—lymph node—prostate cancer	0.000355	0.00879	CbGeAlD
Vinblastine—ABCC2—prostate gland—prostate cancer	0.000347	0.00859	CbGeAlD
Vinblastine—CYP3A4—Docetaxel—prostate cancer	0.000337	0.000798	CbGbCtD
Vinblastine—TUBB—urethra—prostate cancer	0.000337	0.00834	CbGeAlD
Vinblastine—TUBB6—renal system—prostate cancer	0.000337	0.00833	CbGeAlD
Vinblastine—TUBB2A—urethra—prostate cancer	0.000335	0.00829	CbGeAlD
Vinblastine—TUBA1A—bone marrow—prostate cancer	0.000332	0.00821	CbGeAlD
Vinblastine—TUBB6—urethra—prostate cancer	0.000331	0.00818	CbGeAlD
Vinblastine—JUN—bone marrow—prostate cancer	0.000329	0.00813	CbGeAlD
Vinblastine—Vincristine—SLC22A3—prostate cancer	0.000328	0.201	CrCbGaD
Vinblastine—ABCC1—prostate gland—prostate cancer	0.000306	0.00757	CbGeAlD
Vinblastine—ABCB11—testis—prostate cancer	0.000301	0.00744	CbGeAlD
Vinblastine—TUBB4B—renal system—prostate cancer	0.000293	0.00724	CbGeAlD
Vinblastine—TUBB4B—urethra—prostate cancer	0.000287	0.00711	CbGeAlD
Vinblastine—TUBA1A—testis—prostate cancer	0.000284	0.00702	CbGeAlD
Vinblastine—JUN—testis—prostate cancer	0.000281	0.00695	CbGeAlD
Vinblastine—TUBB—bone marrow—prostate cancer	0.000259	0.00642	CbGeAlD
Vinblastine—ABCC1—seminal vesicle—prostate cancer	0.000259	0.0064	CbGeAlD
Vinblastine—TUBB2A—bone marrow—prostate cancer	0.000258	0.00638	CbGeAlD
Vinblastine—TUBB6—bone marrow—prostate cancer	0.000254	0.0063	CbGeAlD
Vinblastine—CYP3A4—Doxorubicin—prostate cancer	0.000251	0.000595	CbGbCtD
Vinblastine—TUBB4A—testis—prostate cancer	0.000242	0.006	CbGeAlD
Vinblastine—ABCC2—renal system—prostate cancer	0.000237	0.00585	CbGeAlD
Vinblastine—TUBB2B—testis—prostate cancer	0.000234	0.0058	CbGeAlD
Vinblastine—Vindesine—CYP3A4—prostate cancer	0.000222	0.136	CrCbGaD
Vinblastine—TUBB—testis—prostate cancer	0.000222	0.00549	CbGeAlD
Vinblastine—TUBB4B—bone marrow—prostate cancer	0.000221	0.00547	CbGeAlD
Vinblastine—TUBB2A—testis—prostate cancer	0.000221	0.00546	CbGeAlD
Vinblastine—TUBB6—testis—prostate cancer	0.000218	0.00538	CbGeAlD
Vinblastine—TUBA1A—lymph node—prostate cancer	0.000206	0.00509	CbGeAlD
Vinblastine—ABCC1—urethra—prostate cancer	0.000205	0.00507	CbGeAlD
Vinblastine—JUN—lymph node—prostate cancer	0.000204	0.00504	CbGeAlD
Vinblastine—Vincristine—CYP3A5—prostate cancer	0.00019	0.116	CrCbGaD
Vinblastine—TUBB4B—testis—prostate cancer	0.000189	0.00468	CbGeAlD
Vinblastine—TUBB4A—lymph node—prostate cancer	0.000176	0.00435	CbGeAlD
Vinblastine—TUBB2B—lymph node—prostate cancer	0.00017	0.0042	CbGeAlD
Vinblastine—TUBB—lymph node—prostate cancer	0.000161	0.00398	CbGeAlD
Vinblastine—TUBB2A—lymph node—prostate cancer	0.00016	0.00396	CbGeAlD
Vinblastine—TUBB6—lymph node—prostate cancer	0.000158	0.0039	CbGeAlD
Vinblastine—ABCC2—testis—prostate cancer	0.000153	0.00378	CbGeAlD
Vinblastine—TUBB4B—lymph node—prostate cancer	0.000137	0.00339	CbGeAlD
Vinblastine—ABCC1—testis—prostate cancer	0.000135	0.00333	CbGeAlD
Vinblastine—TUBB6—Fulvestrant—Estradiol—prostate cancer	0.000134	0.091	CbGdCrCtD
Vinblastine—ABCB1—prostate gland—prostate cancer	0.000125	0.00309	CbGeAlD
Vinblastine—CYP3A4—renal system—prostate cancer	0.00012	0.00297	CbGeAlD
Vinblastine—CYP2D6—renal system—prostate cancer	0.000118	0.00293	CbGeAlD
Vinblastine—TUBB6—Levorphanol—Estrone—prostate cancer	0.000117	0.0794	CbGdCrCtD
Vinblastine—ABCC2—lymph node—prostate cancer	0.000111	0.00274	CbGeAlD
Vinblastine—Vinorelbine—CYP3A4—prostate cancer	0.000109	0.0663	CrCbGaD
Vinblastine—ABCB1—seminal vesicle—prostate cancer	0.000106	0.00261	CbGeAlD
Vinblastine—ABCC1—lymph node—prostate cancer	9.76e-05	0.00242	CbGeAlD
Vinblastine—ABCB1—epithelium—prostate cancer	9.17e-05	0.00227	CbGeAlD
Vinblastine—TUBB6—Levorphanol—Estradiol—prostate cancer	8.84e-05	0.0602	CbGdCrCtD
Vinblastine—ABCB1—renal system—prostate cancer	8.51e-05	0.00211	CbGeAlD
Vinblastine—ABCB1—urethra—prostate cancer	8.36e-05	0.00207	CbGeAlD
Vinblastine—Vincristine—CYP3A4—prostate cancer	8.23e-05	0.0503	CrCbGaD
Vinblastine—Angina pectoris—Capecitabine—prostate cancer	7.7e-05	0.00115	CcSEcCtD
Vinblastine—CYP2D6—testis—prostate cancer	7.64e-05	0.00189	CbGeAlD
Vinblastine—Ill-defined disorder—Mitoxantrone—prostate cancer	7.63e-05	0.00114	CcSEcCtD
Vinblastine—Hypertension—Estradiol—prostate cancer	7.62e-05	0.00114	CcSEcCtD
Vinblastine—Anaemia—Mitoxantrone—prostate cancer	7.61e-05	0.00114	CcSEcCtD
Vinblastine—Diarrhoea—Ethinyl Estradiol—prostate cancer	7.56e-05	0.00113	CcSEcCtD
Vinblastine—Pancytopenia—Capecitabine—prostate cancer	7.51e-05	0.00112	CcSEcCtD
Vinblastine—Feeling abnormal—Goserelin—prostate cancer	7.49e-05	0.00112	CcSEcCtD
Vinblastine—Gastrointestinal pain—Goserelin—prostate cancer	7.43e-05	0.00111	CcSEcCtD
Vinblastine—Discomfort—Estradiol—prostate cancer	7.43e-05	0.00111	CcSEcCtD
Vinblastine—Malaise—Mitoxantrone—prostate cancer	7.42e-05	0.00111	CcSEcCtD
Vinblastine—Phlebitis—Epirubicin—prostate cancer	7.39e-05	0.00111	CcSEcCtD
Vinblastine—Leukopenia—Mitoxantrone—prostate cancer	7.37e-05	0.0011	CcSEcCtD
Vinblastine—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	7.36e-05	0.0011	CcSEcCtD
Vinblastine—Neoplasm—Doxorubicin—prostate cancer	7.34e-05	0.0011	CcSEcCtD
Vinblastine—Dizziness—Ethinyl Estradiol—prostate cancer	7.3e-05	0.00109	CcSEcCtD
Vinblastine—Abdominal pain—Goserelin—prostate cancer	7.19e-05	0.00108	CcSEcCtD
Vinblastine—Acute coronary syndrome—Docetaxel—prostate cancer	7.18e-05	0.00108	CcSEcCtD
Vinblastine—Myocardial infarction—Docetaxel—prostate cancer	7.13e-05	0.00107	CcSEcCtD
Vinblastine—Neuropathy peripheral—Docetaxel—prostate cancer	7.13e-05	0.00107	CcSEcCtD
Vinblastine—Convulsion—Mitoxantrone—prostate cancer	7.13e-05	0.00107	CcSEcCtD
Vinblastine—Abdominal pain—Conjugated Estrogens—prostate cancer	7.12e-05	0.00107	CcSEcCtD
Vinblastine—Hypertension—Mitoxantrone—prostate cancer	7.1e-05	0.00106	CcSEcCtD
Vinblastine—Depression—Capecitabine—prostate cancer	7.03e-05	0.00105	CcSEcCtD
Vinblastine—Vomiting—Ethinyl Estradiol—prostate cancer	7.02e-05	0.00105	CcSEcCtD
Vinblastine—Alopecia—Etoposide—prostate cancer	6.95e-05	0.00104	CcSEcCtD
Vinblastine—Acute coronary syndrome—Capecitabine—prostate cancer	6.95e-05	0.00104	CcSEcCtD
Vinblastine—Discomfort—Mitoxantrone—prostate cancer	6.92e-05	0.00104	CcSEcCtD
Vinblastine—Headache—Ethinyl Estradiol—prostate cancer	6.92e-05	0.00104	CcSEcCtD
Vinblastine—Neuropathy peripheral—Capecitabine—prostate cancer	6.91e-05	0.00104	CcSEcCtD
Vinblastine—Myocardial infarction—Capecitabine—prostate cancer	6.91e-05	0.00104	CcSEcCtD
Vinblastine—Phlebitis—Doxorubicin—prostate cancer	6.84e-05	0.00103	CcSEcCtD
Vinblastine—Agranulocytosis—Docetaxel—prostate cancer	6.79e-05	0.00102	CcSEcCtD
Vinblastine—Hypersensitivity—Goserelin—prostate cancer	6.7e-05	0.001	CcSEcCtD
Vinblastine—Hypersensitivity—Conjugated Estrogens—prostate cancer	6.63e-05	0.000994	CcSEcCtD
Vinblastine—Agranulocytosis—Capecitabine—prostate cancer	6.58e-05	0.000986	CcSEcCtD
Vinblastine—Thrombocytopenia—Mitoxantrone—prostate cancer	6.57e-05	0.000985	CcSEcCtD
Vinblastine—Haemoglobin—Docetaxel—prostate cancer	6.57e-05	0.000984	CcSEcCtD
Vinblastine—Nausea—Ethinyl Estradiol—prostate cancer	6.56e-05	0.000983	CcSEcCtD
Vinblastine—Haemorrhage—Docetaxel—prostate cancer	6.53e-05	0.000979	CcSEcCtD
Vinblastine—Asthenia—Goserelin—prostate cancer	6.52e-05	0.000978	CcSEcCtD
Vinblastine—Hypoaesthesia—Docetaxel—prostate cancer	6.5e-05	0.000974	CcSEcCtD
Vinblastine—Cerebrovascular accident—Epirubicin—prostate cancer	6.5e-05	0.000974	CcSEcCtD
Vinblastine—Pharyngitis—Docetaxel—prostate cancer	6.48e-05	0.000972	CcSEcCtD
Vinblastine—Paraesthesia—Estradiol—prostate cancer	6.47e-05	0.00097	CcSEcCtD
Vinblastine—Asthenia—Conjugated Estrogens—prostate cancer	6.46e-05	0.000968	CcSEcCtD
Vinblastine—ABCB1—bone marrow—prostate cancer	6.43e-05	0.00159	CbGeAlD
Vinblastine—Anorexia—Mitoxantrone—prostate cancer	6.4e-05	0.000959	CcSEcCtD
Vinblastine—Haemoglobin—Capecitabine—prostate cancer	6.36e-05	0.000953	CcSEcCtD
Vinblastine—Ill-defined disorder—Etoposide—prostate cancer	6.35e-05	0.000952	CcSEcCtD
Vinblastine—Haemorrhage—Capecitabine—prostate cancer	6.33e-05	0.000948	CcSEcCtD
Vinblastine—Anaemia—Etoposide—prostate cancer	6.33e-05	0.000948	CcSEcCtD
Vinblastine—JUN—Betamethasone—Prednisone—prostate cancer	6.29e-05	0.0428	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Prednisone—prostate cancer	6.29e-05	0.0428	CbGdCrCtD
Vinblastine—Hypoaesthesia—Capecitabine—prostate cancer	6.29e-05	0.000943	CcSEcCtD
Vinblastine—Pharyngitis—Capecitabine—prostate cancer	6.28e-05	0.000941	CcSEcCtD
Vinblastine—Decreased appetite—Estradiol—prostate cancer	6.27e-05	0.000939	CcSEcCtD
Vinblastine—Depression—Prednisone—prostate cancer	6.26e-05	0.000938	CcSEcCtD
Vinblastine—Diarrhoea—Goserelin—prostate cancer	6.22e-05	0.000932	CcSEcCtD
Vinblastine—Acute coronary syndrome—Prednisone—prostate cancer	6.19e-05	0.000927	CcSEcCtD
Vinblastine—Malaise—Etoposide—prostate cancer	6.17e-05	0.000925	CcSEcCtD
Vinblastine—Constipation—Estradiol—prostate cancer	6.16e-05	0.000924	CcSEcCtD
Vinblastine—Pain—Estradiol—prostate cancer	6.16e-05	0.000924	CcSEcCtD
Vinblastine—Diarrhoea—Conjugated Estrogens—prostate cancer	6.16e-05	0.000923	CcSEcCtD
Vinblastine—Myocardial infarction—Prednisone—prostate cancer	6.15e-05	0.000922	CcSEcCtD
Vinblastine—Neuropathy peripheral—Prednisone—prostate cancer	6.15e-05	0.000922	CcSEcCtD
Vinblastine—Vertigo—Etoposide—prostate cancer	6.15e-05	0.000922	CcSEcCtD
Vinblastine—Leukopenia—Etoposide—prostate cancer	6.13e-05	0.000918	CcSEcCtD
Vinblastine—Paraesthesia—Mitoxantrone—prostate cancer	6.03e-05	0.000904	CcSEcCtD
Vinblastine—Cerebrovascular accident—Doxorubicin—prostate cancer	6.02e-05	0.000902	CcSEcCtD
Vinblastine—Dizziness—Goserelin—prostate cancer	6.01e-05	0.000901	CcSEcCtD
Vinblastine—Dizziness—Conjugated Estrogens—prostate cancer	5.95e-05	0.000893	CcSEcCtD
Vinblastine—Feeling abnormal—Estradiol—prostate cancer	5.94e-05	0.00089	CcSEcCtD
Vinblastine—Convulsion—Etoposide—prostate cancer	5.93e-05	0.000889	CcSEcCtD
Vinblastine—Hypertension—Etoposide—prostate cancer	5.91e-05	0.000886	CcSEcCtD
Vinblastine—Gastrointestinal pain—Estradiol—prostate cancer	5.89e-05	0.000883	CcSEcCtD
Vinblastine—Decreased appetite—Mitoxantrone—prostate cancer	5.84e-05	0.000875	CcSEcCtD
Vinblastine—Vomiting—Goserelin—prostate cancer	5.78e-05	0.000866	CcSEcCtD
Vinblastine—Alopecia—Docetaxel—prostate cancer	5.77e-05	0.000865	CcSEcCtD
Vinblastine—Discomfort—Etoposide—prostate cancer	5.76e-05	0.000863	CcSEcCtD
Vinblastine—Pain—Mitoxantrone—prostate cancer	5.74e-05	0.000861	CcSEcCtD
Vinblastine—Constipation—Mitoxantrone—prostate cancer	5.74e-05	0.000861	CcSEcCtD
Vinblastine—Vomiting—Conjugated Estrogens—prostate cancer	5.73e-05	0.000858	CcSEcCtD
Vinblastine—Abdominal pain—Estradiol—prostate cancer	5.7e-05	0.000854	CcSEcCtD
Vinblastine—Headache—Goserelin—prostate cancer	5.7e-05	0.000854	CcSEcCtD
Vinblastine—Haemoglobin—Prednisone—prostate cancer	5.66e-05	0.000849	CcSEcCtD
Vinblastine—Headache—Conjugated Estrogens—prostate cancer	5.64e-05	0.000846	CcSEcCtD
Vinblastine—Haemorrhage—Prednisone—prostate cancer	5.63e-05	0.000845	CcSEcCtD
Vinblastine—Alopecia—Capecitabine—prostate cancer	5.59e-05	0.000838	CcSEcCtD
Vinblastine—Feeling abnormal—Mitoxantrone—prostate cancer	5.53e-05	0.000829	CcSEcCtD
Vinblastine—ABCB1—testis—prostate cancer	5.5e-05	0.00136	CbGeAlD
Vinblastine—Gastrointestinal pain—Mitoxantrone—prostate cancer	5.49e-05	0.000823	CcSEcCtD
Vinblastine—Thrombocytopenia—Etoposide—prostate cancer	5.47e-05	0.00082	CcSEcCtD
Vinblastine—Nausea—Goserelin—prostate cancer	5.4e-05	0.000809	CcSEcCtD
Vinblastine—Angina pectoris—Epirubicin—prostate cancer	5.36e-05	0.000804	CcSEcCtD
Vinblastine—Nausea—Conjugated Estrogens—prostate cancer	5.35e-05	0.000802	CcSEcCtD
Vinblastine—Anorexia—Etoposide—prostate cancer	5.32e-05	0.000798	CcSEcCtD
Vinblastine—Hypersensitivity—Estradiol—prostate cancer	5.31e-05	0.000796	CcSEcCtD
Vinblastine—Abdominal pain—Mitoxantrone—prostate cancer	5.31e-05	0.000796	CcSEcCtD
Vinblastine—Anaemia—Docetaxel—prostate cancer	5.26e-05	0.000788	CcSEcCtD
Vinblastine—Pancytopenia—Epirubicin—prostate cancer	5.23e-05	0.000784	CcSEcCtD
Vinblastine—Asthenia—Estradiol—prostate cancer	5.17e-05	0.000775	CcSEcCtD
Vinblastine—Ill-defined disorder—Capecitabine—prostate cancer	5.11e-05	0.000766	CcSEcCtD
Vinblastine—Leukopenia—Docetaxel—prostate cancer	5.09e-05	0.000763	CcSEcCtD
Vinblastine—Anaemia—Capecitabine—prostate cancer	5.09e-05	0.000763	CcSEcCtD
Vinblastine—Paraesthesia—Etoposide—prostate cancer	5.02e-05	0.000752	CcSEcCtD
Vinblastine—Alopecia—Prednisone—prostate cancer	4.98e-05	0.000746	CcSEcCtD
Vinblastine—Malaise—Capecitabine—prostate cancer	4.97e-05	0.000744	CcSEcCtD
Vinblastine—Angina pectoris—Doxorubicin—prostate cancer	4.96e-05	0.000744	CcSEcCtD
Vinblastine—Vertigo—Capecitabine—prostate cancer	4.95e-05	0.000742	CcSEcCtD
Vinblastine—Hypersensitivity—Mitoxantrone—prostate cancer	4.95e-05	0.000742	CcSEcCtD
Vinblastine—Diarrhoea—Estradiol—prostate cancer	4.93e-05	0.000739	CcSEcCtD
Vinblastine—Leukopenia—Capecitabine—prostate cancer	4.93e-05	0.000739	CcSEcCtD
Vinblastine—Convulsion—Docetaxel—prostate cancer	4.93e-05	0.000739	CcSEcCtD
Vinblastine—Hypertension—Docetaxel—prostate cancer	4.91e-05	0.000736	CcSEcCtD
Vinblastine—Decreased appetite—Etoposide—prostate cancer	4.86e-05	0.000728	CcSEcCtD
Vinblastine—Pancytopenia—Doxorubicin—prostate cancer	4.84e-05	0.000725	CcSEcCtD
Vinblastine—Asthenia—Mitoxantrone—prostate cancer	4.82e-05	0.000722	CcSEcCtD
Vinblastine—Neuropathy peripheral—Epirubicin—prostate cancer	4.81e-05	0.000721	CcSEcCtD
Vinblastine—Pain—Etoposide—prostate cancer	4.78e-05	0.000716	CcSEcCtD
Vinblastine—Constipation—Etoposide—prostate cancer	4.78e-05	0.000716	CcSEcCtD
Vinblastine—Dizziness—Estradiol—prostate cancer	4.77e-05	0.000714	CcSEcCtD
Vinblastine—Hypertension—Capecitabine—prostate cancer	4.75e-05	0.000713	CcSEcCtD
Vinblastine—Discomfort—Capecitabine—prostate cancer	4.63e-05	0.000694	CcSEcCtD
Vinblastine—Feeling abnormal—Etoposide—prostate cancer	4.6e-05	0.00069	CcSEcCtD
Vinblastine—Diarrhoea—Mitoxantrone—prostate cancer	4.59e-05	0.000689	CcSEcCtD
Vinblastine—Vomiting—Estradiol—prostate cancer	4.58e-05	0.000687	CcSEcCtD
Vinblastine—Agranulocytosis—Epirubicin—prostate cancer	4.58e-05	0.000687	CcSEcCtD
Vinblastine—Gastrointestinal pain—Etoposide—prostate cancer	4.57e-05	0.000685	CcSEcCtD
Vinblastine—Ill-defined disorder—Prednisone—prostate cancer	4.55e-05	0.000682	CcSEcCtD
Vinblastine—Thrombocytopenia—Docetaxel—prostate cancer	4.55e-05	0.000681	CcSEcCtD
Vinblastine—Anaemia—Prednisone—prostate cancer	4.53e-05	0.00068	CcSEcCtD
Vinblastine—Headache—Estradiol—prostate cancer	4.51e-05	0.000677	CcSEcCtD
Vinblastine—Neuropathy peripheral—Doxorubicin—prostate cancer	4.45e-05	0.000667	CcSEcCtD
Vinblastine—Haemoglobin—Epirubicin—prostate cancer	4.43e-05	0.000664	CcSEcCtD
Vinblastine—Anorexia—Docetaxel—prostate cancer	4.42e-05	0.000663	CcSEcCtD
Vinblastine—Malaise—Prednisone—prostate cancer	4.42e-05	0.000663	CcSEcCtD
Vinblastine—Abdominal pain—Etoposide—prostate cancer	4.42e-05	0.000662	CcSEcCtD
Vinblastine—Vertigo—Prednisone—prostate cancer	4.41e-05	0.000661	CcSEcCtD
Vinblastine—Haemorrhage—Epirubicin—prostate cancer	4.41e-05	0.000661	CcSEcCtD
Vinblastine—Thrombocytopenia—Capecitabine—prostate cancer	4.4e-05	0.00066	CcSEcCtD
Vinblastine—Hypoaesthesia—Epirubicin—prostate cancer	4.39e-05	0.000657	CcSEcCtD
Vinblastine—Pharyngitis—Epirubicin—prostate cancer	4.37e-05	0.000656	CcSEcCtD
Vinblastine—Anorexia—Capecitabine—prostate cancer	4.28e-05	0.000642	CcSEcCtD
Vinblastine—Nausea—Estradiol—prostate cancer	4.28e-05	0.000642	CcSEcCtD
Vinblastine—Vomiting—Mitoxantrone—prostate cancer	4.27e-05	0.00064	CcSEcCtD
Vinblastine—Convulsion—Prednisone—prostate cancer	4.25e-05	0.000637	CcSEcCtD
Vinblastine—Agranulocytosis—Doxorubicin—prostate cancer	4.24e-05	0.000635	CcSEcCtD
Vinblastine—Hypertension—Prednisone—prostate cancer	4.24e-05	0.000635	CcSEcCtD
Vinblastine—Headache—Mitoxantrone—prostate cancer	4.21e-05	0.000631	CcSEcCtD
Vinblastine—Paraesthesia—Docetaxel—prostate cancer	4.17e-05	0.000625	CcSEcCtD
Vinblastine—Discomfort—Prednisone—prostate cancer	4.13e-05	0.000618	CcSEcCtD
Vinblastine—Hypersensitivity—Etoposide—prostate cancer	4.12e-05	0.000617	CcSEcCtD
Vinblastine—Haemoglobin—Doxorubicin—prostate cancer	4.1e-05	0.000614	CcSEcCtD
Vinblastine—Haemorrhage—Doxorubicin—prostate cancer	4.08e-05	0.000611	CcSEcCtD
Vinblastine—Hypoaesthesia—Doxorubicin—prostate cancer	4.06e-05	0.000608	CcSEcCtD
Vinblastine—Pharyngitis—Doxorubicin—prostate cancer	4.05e-05	0.000607	CcSEcCtD
Vinblastine—Paraesthesia—Capecitabine—prostate cancer	4.04e-05	0.000605	CcSEcCtD
Vinblastine—Decreased appetite—Docetaxel—prostate cancer	4.04e-05	0.000605	CcSEcCtD
Vinblastine—Asthenia—Etoposide—prostate cancer	4.01e-05	0.000601	CcSEcCtD
Vinblastine—Nausea—Mitoxantrone—prostate cancer	3.99e-05	0.000598	CcSEcCtD
Vinblastine—ABCB1—lymph node—prostate cancer	3.99e-05	0.000986	CbGeAlD
Vinblastine—Constipation—Docetaxel—prostate cancer	3.97e-05	0.000595	CcSEcCtD
Vinblastine—Pain—Docetaxel—prostate cancer	3.97e-05	0.000595	CcSEcCtD
Vinblastine—Decreased appetite—Capecitabine—prostate cancer	3.91e-05	0.000586	CcSEcCtD
Vinblastine—Alopecia—Epirubicin—prostate cancer	3.89e-05	0.000584	CcSEcCtD
Vinblastine—Constipation—Capecitabine—prostate cancer	3.84e-05	0.000576	CcSEcCtD
Vinblastine—Pain—Capecitabine—prostate cancer	3.84e-05	0.000576	CcSEcCtD
Vinblastine—Feeling abnormal—Docetaxel—prostate cancer	3.83e-05	0.000573	CcSEcCtD
Vinblastine—Diarrhoea—Etoposide—prostate cancer	3.82e-05	0.000573	CcSEcCtD
Vinblastine—Anorexia—Prednisone—prostate cancer	3.82e-05	0.000572	CcSEcCtD
Vinblastine—Gastrointestinal pain—Docetaxel—prostate cancer	3.8e-05	0.000569	CcSEcCtD
Vinblastine—Feeling abnormal—Capecitabine—prostate cancer	3.7e-05	0.000555	CcSEcCtD
Vinblastine—Dizziness—Etoposide—prostate cancer	3.69e-05	0.000554	CcSEcCtD
Vinblastine—Gastrointestinal pain—Capecitabine—prostate cancer	3.68e-05	0.000551	CcSEcCtD
Vinblastine—Abdominal pain—Docetaxel—prostate cancer	3.67e-05	0.00055	CcSEcCtD
Vinblastine—Alopecia—Doxorubicin—prostate cancer	3.6e-05	0.00054	CcSEcCtD
Vinblastine—Paraesthesia—Prednisone—prostate cancer	3.59e-05	0.000539	CcSEcCtD
Vinblastine—Ill-defined disorder—Epirubicin—prostate cancer	3.56e-05	0.000534	CcSEcCtD
Vinblastine—Abdominal pain—Capecitabine—prostate cancer	3.55e-05	0.000533	CcSEcCtD
Vinblastine—Vomiting—Etoposide—prostate cancer	3.55e-05	0.000532	CcSEcCtD
Vinblastine—Anaemia—Epirubicin—prostate cancer	3.55e-05	0.000531	CcSEcCtD
Vinblastine—Headache—Etoposide—prostate cancer	3.5e-05	0.000524	CcSEcCtD
Vinblastine—Decreased appetite—Prednisone—prostate cancer	3.48e-05	0.000522	CcSEcCtD
Vinblastine—Malaise—Epirubicin—prostate cancer	3.46e-05	0.000519	CcSEcCtD
Vinblastine—Vertigo—Epirubicin—prostate cancer	3.45e-05	0.000517	CcSEcCtD
Vinblastine—Leukopenia—Epirubicin—prostate cancer	3.43e-05	0.000515	CcSEcCtD
Vinblastine—Constipation—Prednisone—prostate cancer	3.42e-05	0.000513	CcSEcCtD
Vinblastine—Hypersensitivity—Docetaxel—prostate cancer	3.42e-05	0.000513	CcSEcCtD
Vinblastine—Asthenia—Docetaxel—prostate cancer	3.33e-05	0.000499	CcSEcCtD
Vinblastine—Convulsion—Epirubicin—prostate cancer	3.32e-05	0.000498	CcSEcCtD
Vinblastine—Nausea—Etoposide—prostate cancer	3.32e-05	0.000497	CcSEcCtD
Vinblastine—Hypertension—Epirubicin—prostate cancer	3.31e-05	0.000496	CcSEcCtD
Vinblastine—Hypersensitivity—Capecitabine—prostate cancer	3.31e-05	0.000496	CcSEcCtD
Vinblastine—Feeling abnormal—Prednisone—prostate cancer	3.3e-05	0.000494	CcSEcCtD
Vinblastine—Ill-defined disorder—Doxorubicin—prostate cancer	3.29e-05	0.000494	CcSEcCtD
Vinblastine—Anaemia—Doxorubicin—prostate cancer	3.28e-05	0.000492	CcSEcCtD
Vinblastine—Gastrointestinal pain—Prednisone—prostate cancer	3.27e-05	0.000491	CcSEcCtD
Vinblastine—Discomfort—Epirubicin—prostate cancer	3.23e-05	0.000484	CcSEcCtD
Vinblastine—Asthenia—Capecitabine—prostate cancer	3.22e-05	0.000483	CcSEcCtD
Vinblastine—Malaise—Doxorubicin—prostate cancer	3.2e-05	0.00048	CcSEcCtD
Vinblastine—Vertigo—Doxorubicin—prostate cancer	3.19e-05	0.000478	CcSEcCtD
Vinblastine—Leukopenia—Doxorubicin—prostate cancer	3.18e-05	0.000476	CcSEcCtD
Vinblastine—Diarrhoea—Docetaxel—prostate cancer	3.18e-05	0.000476	CcSEcCtD
Vinblastine—Abdominal pain—Prednisone—prostate cancer	3.16e-05	0.000474	CcSEcCtD
Vinblastine—Convulsion—Doxorubicin—prostate cancer	3.08e-05	0.000461	CcSEcCtD
Vinblastine—Diarrhoea—Capecitabine—prostate cancer	3.08e-05	0.000461	CcSEcCtD
Vinblastine—Dizziness—Docetaxel—prostate cancer	3.07e-05	0.00046	CcSEcCtD
Vinblastine—Thrombocytopenia—Epirubicin—prostate cancer	3.07e-05	0.000459	CcSEcCtD
Vinblastine—Hypertension—Doxorubicin—prostate cancer	3.06e-05	0.000459	CcSEcCtD
Vinblastine—Discomfort—Doxorubicin—prostate cancer	2.99e-05	0.000448	CcSEcCtD
Vinblastine—Anorexia—Epirubicin—prostate cancer	2.98e-05	0.000447	CcSEcCtD
Vinblastine—Dizziness—Capecitabine—prostate cancer	2.97e-05	0.000445	CcSEcCtD
Vinblastine—Vomiting—Docetaxel—prostate cancer	2.95e-05	0.000442	CcSEcCtD
Vinblastine—Hypersensitivity—Prednisone—prostate cancer	2.95e-05	0.000442	CcSEcCtD
Vinblastine—Headache—Docetaxel—prostate cancer	2.91e-05	0.000436	CcSEcCtD
Vinblastine—Asthenia—Prednisone—prostate cancer	2.87e-05	0.000431	CcSEcCtD
Vinblastine—Vomiting—Capecitabine—prostate cancer	2.86e-05	0.000428	CcSEcCtD
Vinblastine—Thrombocytopenia—Doxorubicin—prostate cancer	2.84e-05	0.000425	CcSEcCtD
Vinblastine—Headache—Capecitabine—prostate cancer	2.82e-05	0.000422	CcSEcCtD
Vinblastine—Paraesthesia—Epirubicin—prostate cancer	2.81e-05	0.000421	CcSEcCtD
Vinblastine—Anorexia—Doxorubicin—prostate cancer	2.76e-05	0.000414	CcSEcCtD
Vinblastine—Nausea—Docetaxel—prostate cancer	2.76e-05	0.000413	CcSEcCtD
Vinblastine—Diarrhoea—Prednisone—prostate cancer	2.74e-05	0.000411	CcSEcCtD
Vinblastine—Decreased appetite—Epirubicin—prostate cancer	2.72e-05	0.000408	CcSEcCtD
Vinblastine—Pain—Epirubicin—prostate cancer	2.68e-05	0.000401	CcSEcCtD
Vinblastine—Constipation—Epirubicin—prostate cancer	2.68e-05	0.000401	CcSEcCtD
Vinblastine—Nausea—Capecitabine—prostate cancer	2.67e-05	0.0004	CcSEcCtD
Vinblastine—Dizziness—Prednisone—prostate cancer	2.65e-05	0.000397	CcSEcCtD
Vinblastine—Paraesthesia—Doxorubicin—prostate cancer	2.6e-05	0.00039	CcSEcCtD
Vinblastine—Feeling abnormal—Epirubicin—prostate cancer	2.58e-05	0.000387	CcSEcCtD
Vinblastine—Gastrointestinal pain—Epirubicin—prostate cancer	2.56e-05	0.000384	CcSEcCtD
Vinblastine—Vomiting—Prednisone—prostate cancer	2.55e-05	0.000382	CcSEcCtD
Vinblastine—Decreased appetite—Doxorubicin—prostate cancer	2.52e-05	0.000377	CcSEcCtD
Vinblastine—Headache—Prednisone—prostate cancer	2.51e-05	0.000376	CcSEcCtD
Vinblastine—Pain—Doxorubicin—prostate cancer	2.48e-05	0.000371	CcSEcCtD
Vinblastine—Constipation—Doxorubicin—prostate cancer	2.48e-05	0.000371	CcSEcCtD
Vinblastine—Abdominal pain—Epirubicin—prostate cancer	2.48e-05	0.000371	CcSEcCtD
Vinblastine—Feeling abnormal—Doxorubicin—prostate cancer	2.39e-05	0.000358	CcSEcCtD
Vinblastine—Nausea—Prednisone—prostate cancer	2.38e-05	0.000356	CcSEcCtD
Vinblastine—Gastrointestinal pain—Doxorubicin—prostate cancer	2.37e-05	0.000355	CcSEcCtD
Vinblastine—Hypersensitivity—Epirubicin—prostate cancer	2.31e-05	0.000346	CcSEcCtD
Vinblastine—Abdominal pain—Doxorubicin—prostate cancer	2.29e-05	0.000343	CcSEcCtD
Vinblastine—Asthenia—Epirubicin—prostate cancer	2.25e-05	0.000337	CcSEcCtD
Vinblastine—Diarrhoea—Epirubicin—prostate cancer	2.14e-05	0.000321	CcSEcCtD
Vinblastine—Hypersensitivity—Doxorubicin—prostate cancer	2.13e-05	0.00032	CcSEcCtD
Vinblastine—Asthenia—Doxorubicin—prostate cancer	2.08e-05	0.000312	CcSEcCtD
Vinblastine—Dizziness—Epirubicin—prostate cancer	2.07e-05	0.00031	CcSEcCtD
Vinblastine—Vomiting—Epirubicin—prostate cancer	1.99e-05	0.000298	CcSEcCtD
Vinblastine—Diarrhoea—Doxorubicin—prostate cancer	1.98e-05	0.000297	CcSEcCtD
Vinblastine—Headache—Epirubicin—prostate cancer	1.96e-05	0.000294	CcSEcCtD
Vinblastine—Dizziness—Doxorubicin—prostate cancer	1.92e-05	0.000287	CcSEcCtD
Vinblastine—Nausea—Epirubicin—prostate cancer	1.86e-05	0.000279	CcSEcCtD
Vinblastine—Vomiting—Doxorubicin—prostate cancer	1.84e-05	0.000276	CcSEcCtD
Vinblastine—Headache—Doxorubicin—prostate cancer	1.81e-05	0.000272	CcSEcCtD
Vinblastine—Nausea—Doxorubicin—prostate cancer	1.72e-05	0.000258	CcSEcCtD
Vinblastine—JUN—Innate Immune System—AKT1—prostate cancer	1.05e-06	1.37e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NCOA3—prostate cancer	1.05e-06	1.37e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CB—prostate cancer	1.04e-06	1.36e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPARA—prostate cancer	1.04e-06	1.36e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CG—prostate cancer	1.04e-06	1.35e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—APC—prostate cancer	1.04e-06	1.35e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—UMPS—prostate cancer	1.04e-06	1.35e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ARG2—prostate cancer	1.04e-06	1.35e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PHGDH—prostate cancer	1.04e-06	1.35e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTGS2—prostate cancer	1.03e-06	1.35e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTT1—prostate cancer	1.03e-06	1.34e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ACHE—prostate cancer	1.03e-06	1.34e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—FGF2—prostate cancer	1.03e-06	1.34e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EGF—prostate cancer	1.02e-06	1.34e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IRS1—prostate cancer	1.02e-06	1.34e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CG—prostate cancer	1.02e-06	1.34e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP2A6—prostate cancer	1.02e-06	1.33e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LDHB—prostate cancer	1.02e-06	1.32e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NOS3—prostate cancer	1.01e-06	1.32e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—EP300—prostate cancer	1.01e-06	1.32e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HPGDS—prostate cancer	1e-06	1.3e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	9.99e-07	1.3e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP3A5—prostate cancer	9.96e-07	1.3e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—GSK3B—prostate cancer	9.95e-07	1.3e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP2C19—prostate cancer	9.94e-07	1.3e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AKR1C3—prostate cancer	9.9e-07	1.29e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—JAK2—prostate cancer	9.86e-07	1.29e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PRKACB—prostate cancer	9.85e-07	1.28e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—SRC—prostate cancer	9.85e-07	1.28e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—INS—prostate cancer	9.81e-07	1.28e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CAV1—prostate cancer	9.79e-07	1.28e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP17A1—prostate cancer	9.75e-07	1.27e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ACHE—prostate cancer	9.7e-07	1.27e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTT1—prostate cancer	9.7e-07	1.27e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—INS—prostate cancer	9.69e-07	1.26e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	9.64e-07	1.26e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MDM2—prostate cancer	9.63e-07	1.26e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PDHA1—prostate cancer	9.62e-07	1.25e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TCN2—prostate cancer	9.62e-07	1.25e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—UCP3—prostate cancer	9.62e-07	1.25e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTA3—prostate cancer	9.62e-07	1.25e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CREBBP—prostate cancer	9.61e-07	1.25e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP2A6—prostate cancer	9.59e-07	1.25e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—STAT3—prostate cancer	9.5e-07	1.24e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IGF1—prostate cancer	9.49e-07	1.24e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CREBBP—prostate cancer	9.49e-07	1.24e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ERBB2—prostate cancer	9.49e-07	1.24e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CB—prostate cancer	9.37e-07	1.22e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AKR1C3—prostate cancer	9.33e-07	1.22e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NCOA2—prostate cancer	9.29e-07	1.21e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PRKACB—prostate cancer	9.28e-07	1.21e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTGS2—prostate cancer	9.28e-07	1.21e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP17A1—prostate cancer	9.19e-07	1.2e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC22A3—prostate cancer	9.18e-07	1.2e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HSD3B1—prostate cancer	9.18e-07	1.2e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAP2K1—prostate cancer	9.17e-07	1.2e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CD—prostate cancer	9.11e-07	1.19e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTEN—prostate cancer	9.02e-07	1.18e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SERPINE1—prostate cancer	9.01e-07	1.18e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CD—prostate cancer	9e-07	1.17e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CG—prostate cancer	8.92e-07	1.16e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC5A5—prostate cancer	8.86e-07	1.16e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TBXAS1—prostate cancer	8.8e-07	1.15e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTA4—prostate cancer	8.8e-07	1.15e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDKN1B—prostate cancer	8.79e-07	1.15e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NCOA2—prostate cancer	8.75e-07	1.14e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FGF2—prostate cancer	8.73e-07	1.14e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP2E1—prostate cancer	8.65e-07	1.13e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—EGFR—prostate cancer	8.63e-07	1.13e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NOS3—prostate cancer	8.61e-07	1.12e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—EP300—prostate cancer	8.61e-07	1.12e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTA2—prostate cancer	8.58e-07	1.12e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NQO1—prostate cancer	8.56e-07	1.12e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—NOS3—prostate cancer	8.5e-07	1.11e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ABCG5—prostate cancer	8.47e-07	1.1e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SULT1A1—prostate cancer	8.47e-07	1.1e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—INS—prostate cancer	8.44e-07	1.1e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—TH—prostate cancer	8.43e-07	1.1e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—JAK2—prostate cancer	8.36e-07	1.09e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC5A5—prostate cancer	8.35e-07	1.09e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP3A4—prostate cancer	8.35e-07	1.09e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CTNNB1—prostate cancer	8.3e-07	1.08e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTA1—prostate cancer	8.27e-07	1.08e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CREBBP—prostate cancer	8.27e-07	1.08e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP1B1—prostate cancer	8.2e-07	1.07e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HSD3B2—prostate cancer	8.18e-07	1.07e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NAT2—prostate cancer	8.18e-07	1.07e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTO1—prostate cancer	8.18e-07	1.07e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MDM2—prostate cancer	8.16e-07	1.06e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP2E1—prostate cancer	8.16e-07	1.06e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—KRAS—prostate cancer	8.15e-07	1.06e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDKN1A—prostate cancer	8.11e-07	1.06e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTEN—prostate cancer	8.09e-07	1.06e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NQO1—prostate cancer	8.06e-07	1.05e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ERBB2—prostate cancer	8.05e-07	1.05e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—TH—prostate cancer	7.95e-07	1.04e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GGT1—prostate cancer	7.95e-07	1.04e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CB—prostate cancer	7.94e-07	1.04e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP3A4—prostate cancer	7.86e-07	1.03e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PLCB2—prostate cancer	7.84e-07	1.02e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LRP2—prostate cancer	7.84e-07	1.02e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP2C18—prostate cancer	7.84e-07	1.02e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CB—prostate cancer	7.84e-07	1.02e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CD—prostate cancer	7.84e-07	1.02e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NCOA1—prostate cancer	7.83e-07	1.02e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTGS2—prostate cancer	7.77e-07	1.01e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP1B1—prostate cancer	7.73e-07	1.01e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—EP300—prostate cancer	7.72e-07	1.01e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP19A1—prostate cancer	7.71e-07	1.01e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—P4HB—prostate cancer	7.69e-07	1e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CXCL8—prostate cancer	7.63e-07	9.95e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—SRC—prostate cancer	7.51e-07	9.79e-06	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CA—prostate cancer	7.49e-07	9.77e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GGT1—prostate cancer	7.49e-07	9.76e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC22A1—prostate cancer	7.48e-07	9.76e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN1B—prostate cancer	7.45e-07	9.72e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—RXRA—prostate cancer	7.44e-07	9.71e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—NOS3—prostate cancer	7.4e-07	9.65e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NCOA1—prostate cancer	7.38e-07	9.62e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CASP3—prostate cancer	7.31e-07	9.53e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL2—prostate cancer	7.3e-07	9.51e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SULT2A1—prostate cancer	7.29e-07	9.51e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP19A1—prostate cancer	7.27e-07	9.48e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—STAT3—prostate cancer	7.24e-07	9.44e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MED12—prostate cancer	7.17e-07	9.36e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—COMT—prostate cancer	7.17e-07	9.35e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTP1—prostate cancer	7.14e-07	9.31e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GNG5—prostate cancer	7.12e-07	9.28e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCND1—prostate cancer	7.11e-07	9.27e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CTNNB1—prostate cancer	7.04e-07	9.18e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ITPR1—prostate cancer	7.02e-07	9.16e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—RXRA—prostate cancer	7.02e-07	9.15e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MMP9—prostate cancer	6.9e-07	9e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN1A—prostate cancer	6.88e-07	8.97e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTEN—prostate cancer	6.86e-07	8.95e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NCOA3—prostate cancer	6.86e-07	8.94e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CB—prostate cancer	6.83e-07	8.91e-06	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTEN—prostate cancer	6.78e-07	8.84e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTGS2—prostate cancer	6.77e-07	8.83e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—COMT—prostate cancer	6.76e-07	8.81e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MYC—prostate cancer	6.73e-07	8.77e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTP1—prostate cancer	6.73e-07	8.77e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TGFB1—prostate cancer	6.71e-07	8.75e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—TYMS—prostate cancer	6.64e-07	8.65e-06	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6—prostate cancer	6.63e-07	8.65e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ITPR1—prostate cancer	6.62e-07	8.63e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—EGFR—prostate cancer	6.58e-07	8.58e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTM1—prostate cancer	6.56e-07	8.55e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EP300—prostate cancer	6.55e-07	8.54e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HPGDS—prostate cancer	6.54e-07	8.53e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.5e-07	8.48e-06	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—EP300—prostate cancer	6.46e-07	8.43e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—LPL—prostate cancer	6.44e-07	8.4e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SRC—prostate cancer	6.37e-07	8.3e-06	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CA—prostate cancer	6.37e-07	8.3e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTT1—prostate cancer	6.34e-07	8.27e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ACHE—prostate cancer	6.34e-07	8.27e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.27e-07	8.18e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—TYMS—prostate cancer	6.25e-07	8.15e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP1A1—prostate cancer	6.22e-07	8.11e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KRAS—prostate cancer	6.22e-07	8.1e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—VEGFA—prostate cancer	6.2e-07	8.09e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTM1—prostate cancer	6.18e-07	8.06e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ERCC2—prostate cancer	6.17e-07	8.04e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—STAT3—prostate cancer	6.14e-07	8.01e-06	CbGpPWpGaD
Vinblastine—JUN—Immune System—AKT1—prostate cancer	6.12e-07	7.98e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.1e-07	7.96e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PRKACB—prostate cancer	6.07e-07	7.91e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—LPL—prostate cancer	6.07e-07	7.91e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.01e-07	7.83e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTEN—prostate cancer	5.9e-07	7.7e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP1A1—prostate cancer	5.86e-07	7.64e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ERCC2—prostate cancer	5.81e-07	7.58e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MTHFR—prostate cancer	5.8e-07	7.56e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NCOA2—prostate cancer	5.72e-07	7.46e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CA—prostate cancer	5.71e-07	7.45e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MYC—prostate cancer	5.7e-07	7.44e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TGFB1—prostate cancer	5.69e-07	7.42e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPARA—prostate cancer	5.69e-07	7.42e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—EP300—prostate cancer	5.63e-07	7.34e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EGFR—prostate cancer	5.58e-07	7.28e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MTHFR—prostate cancer	5.46e-07	7.12e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.46e-07	7.12e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPARA—prostate cancer	5.36e-07	6.99e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CAV1—prostate cancer	5.35e-07	6.97e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.33e-07	6.95e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NQO1—prostate cancer	5.27e-07	6.88e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KRAS—prostate cancer	5.27e-07	6.87e-06	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—AKT1—prostate cancer	5.2e-07	6.78e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TH—prostate cancer	5.2e-07	6.78e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6—prostate cancer	5.06e-07	6.59e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.05e-07	6.59e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CAV1—prostate cancer	5.04e-07	6.57e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GGT1—prostate cancer	4.9e-07	6.38e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CG—prostate cancer	4.87e-07	6.35e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CA—prostate cancer	4.84e-07	6.31e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NCOA1—prostate cancer	4.82e-07	6.29e-06	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CA—prostate cancer	4.78e-07	6.24e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.75e-07	6.2e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TP53—prostate cancer	4.68e-07	6.11e-06	CbGpPWpGaD
Vinblastine—ABCC1—Disease—AKT1—prostate cancer	4.66e-07	6.08e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—INS—prostate cancer	4.61e-07	6.01e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CG—prostate cancer	4.59e-07	5.99e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—RXRA—prostate cancer	4.59e-07	5.98e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CREBBP—prostate cancer	4.52e-07	5.89e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—COMT—prostate cancer	4.42e-07	5.76e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTP1—prostate cancer	4.4e-07	5.73e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—INS—prostate cancer	4.34e-07	5.67e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ITPR1—prostate cancer	4.33e-07	5.64e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6—prostate cancer	4.29e-07	5.59e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CD—prostate cancer	4.28e-07	5.58e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CREBBP—prostate cancer	4.26e-07	5.55e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CA—prostate cancer	4.16e-07	5.43e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TYMS—prostate cancer	4.09e-07	5.33e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NOS3—prostate cancer	4.04e-07	5.27e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTM1—prostate cancer	4.04e-07	5.27e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CD—prostate cancer	4.03e-07	5.26e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LPL—prostate cancer	3.97e-07	5.17e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—AKT1—prostate cancer	3.96e-07	5.16e-06	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—AKT1—prostate cancer	3.91e-07	5.09e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.83e-07	5e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NOS3—prostate cancer	3.81e-07	4.97e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ERCC2—prostate cancer	3.8e-07	4.95e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CB—prostate cancer	3.73e-07	4.87e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTGS2—prostate cancer	3.7e-07	4.82e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MTHFR—prostate cancer	3.57e-07	4.66e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CB—prostate cancer	3.52e-07	4.59e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPARA—prostate cancer	3.5e-07	4.57e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTGS2—prostate cancer	3.48e-07	4.54e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—AKT1—prostate cancer	3.4e-07	4.44e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CAV1—prostate cancer	3.29e-07	4.3e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTEN—prostate cancer	3.22e-07	4.21e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—EP300—prostate cancer	3.08e-07	4.01e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTEN—prostate cancer	3.04e-07	3.96e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CG—prostate cancer	3e-07	3.91e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—EP300—prostate cancer	2.9e-07	3.78e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—INS—prostate cancer	2.84e-07	3.7e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CREBBP—prostate cancer	2.78e-07	3.63e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.64e-07	3.44e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NOS3—prostate cancer	2.49e-07	3.25e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.3e-07	3e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTGS2—prostate cancer	2.28e-07	2.97e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CA—prostate cancer	2.27e-07	2.97e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CA—prostate cancer	2.14e-07	2.8e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTEN—prostate cancer	1.99e-07	2.59e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—EP300—prostate cancer	1.89e-07	2.47e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AKT1—prostate cancer	1.86e-07	2.42e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AKT1—prostate cancer	1.75e-07	2.28e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.4e-07	1.83e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AKT1—prostate cancer	1.15e-07	1.49e-06	CbGpPWpGaD
